Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 85

1.

Proteins are potent biomarkers to detect colon cancer progression.

Kuppusamy P, Govindan N, Yusoff MM, Ichwan SJA.

Saudi J Biol Sci. 2017 Sep;24(6):1212-1221. doi: 10.1016/j.sjbs.2014.09.017. Epub 2014 Oct 5.

2.

Discovery and validation of new potential biomarkers for early detection of colon cancer.

Solé X, Crous-Bou M, Cordero D, Olivares D, Guinó E, Sanz-Pamplona R, Rodriguez-Moranta F, Sanjuan X, de Oca J, Salazar R, Moreno V.

PLoS One. 2014 Sep 12;9(9):e106748. doi: 10.1371/journal.pone.0106748. eCollection 2014.

3.

Urinary biomarkers in prostate cancer detection and monitoring progression.

Wu D, Ni J, Beretov J, Cozzi P, Willcox M, Wasinger V, Walsh B, Graham P, Li Y.

Crit Rev Oncol Hematol. 2017 Oct;118:15-26. doi: 10.1016/j.critrevonc.2017.08.002. Epub 2017 Aug 19. Review.

PMID:
28917266
4.

Bioinformatic identification of proteins with tissue-specific expression for biomarker discovery.

Prassas I, Chrystoja CC, Makawita S, Diamandis EP.

BMC Med. 2012 Apr 19;10:39. doi: 10.1186/1741-7015-10-39.

5.

Discovery of potential colorectal cancer serum biomarkers through quantitative proteomics on the colonic tissue interstitial fluids from the AOM-DSS mouse model.

Wang Y, Shan Q, Hou G, Zhang J, Bai J, Lv X, Xie Y, Zhu H, Su S, Li Y, Zi J, Lin L, Han W, Zhao X, Wang H, Xu N, Wu L, Lou X, Liu S.

J Proteomics. 2016 Jan 30;132:31-40. doi: 10.1016/j.jprot.2015.11.013. Epub 2015 Nov 12.

PMID:
26581642
6.

Prognostic and predictive potential molecular biomarkers in colon cancer.

Nastase A, Pâslaru L, Niculescu AM, Ionescu M, Dumitraşcu T, Herlea V, Dima S, Gheorghe C, Lazar V, Popescu I.

Chirurgia (Bucur). 2011 Mar-Apr;106(2):177-85.

PMID:
21696062
7.

Proteomics in colorectal cancer translational research: biomarker discovery for clinical applications.

de Wit M, Fijneman RJ, Verheul HM, Meijer GA, Jimenez CR.

Clin Biochem. 2013 Apr;46(6):466-79. doi: 10.1016/j.clinbiochem.2012.10.039. Epub 2012 Nov 13. Review.

PMID:
23159294
8.

Proteomic expression analysis of surgical human colorectal cancer tissues: up-regulation of PSB7, PRDX1, and SRP9 and hypoxic adaptation in cancer.

Rho JH, Qin S, Wang JY, Roehrl MH.

J Proteome Res. 2008 Jul;7(7):2959-72. doi: 10.1021/pr8000892. Epub 2008 Jun 13.

9.

Advances in proteomic prostate cancer biomarker discovery.

Goo YA, Goodlett DR.

J Proteomics. 2010 Sep 10;73(10):1839-50. doi: 10.1016/j.jprot.2010.04.002. Epub 2010 Apr 14. Review.

PMID:
20398807
10.

Chromogranin-A Expression as a Novel Biomarker for Early Diagnosis of Colon Cancer Patients.

Zhang X, Zhang H, Shen B, Sun XF.

Int J Mol Sci. 2019 Jun 14;20(12). pii: E2919. doi: 10.3390/ijms20122919.

11.

Linear Discriminant Functions in Connection with the micro-RNA Diagnosis of Colon Cancer.

Nikas JB, Low WC.

Cancer Inform. 2012;11:1-14. doi: 10.4137/CIN.S8779. Epub 2011 Dec 20.

12.

Discovery and preclinical validation of salivary transcriptomic and proteomic biomarkers for the non-invasive detection of breast cancer.

Zhang L, Xiao H, Karlan S, Zhou H, Gross J, Elashoff D, Akin D, Yan X, Chia D, Karlan B, Wong DT.

PLoS One. 2010 Dec 31;5(12):e15573. doi: 10.1371/journal.pone.0015573.

13.

Translationally controlled tumour protein TCTP is induced early in human colorectal tumours and contributes to the resistance of HCT116 colon cancer cells to 5-FU and oxaliplatin.

Bommer UA, Vine KL, Puri P, Engel M, Belfiore L, Fildes K, Batterham M, Lochhead A, Aghmesheh M.

Cell Commun Signal. 2017 Feb 1;15(1):9. doi: 10.1186/s12964-017-0164-3.

14.

Introducing biomarker panel in esophageal, gastric, and colon cancers; a proteomic approach.

Zamanian-Azodi M, Rezaei-Tavirani M, Hasanzadeh H, Rahmati Rad S, Dalilan S.

Gastroenterol Hepatol Bed Bench. 2015 Winter;8(1):6-18. Review.

15.

Investigating neoplastic progression of ulcerative colitis with label-free comparative proteomics.

May D, Pan S, Crispin DA, Lai K, Bronner MP, Hogan J, Hockenbery DM, McIntosh M, Brentnall TA, Chen R.

J Proteome Res. 2011 Jan 7;10(1):200-9. doi: 10.1021/pr100574p. Epub 2010 Oct 20.

16.

Serum biomarkers identification by mass spectrometry in high-mortality tumors.

Tessitore A, Gaggiano A, Cicciarelli G, Verzella D, Capece D, Fischietti M, Zazzeroni F, Alesse E.

Int J Proteomics. 2013;2013:125858. doi: 10.1155/2013/125858. Epub 2013 Jan 15.

17.

Immuno-proteomic discovery of tumor tissue autoantigens identifies olfactomedin 4, CD11b, and integrin alpha-2 as markers of colorectal cancer with liver metastases.

Yang Q, Bavi P, Wang JY, Roehrl MH.

J Proteomics. 2017 Sep 25;168:53-65. doi: 10.1016/j.jprot.2017.06.021. Epub 2017 Jun 29.

PMID:
28669815
18.

Discovery and application of protein biomarkers for ovarian cancer.

Gagnon A, Ye B.

Curr Opin Obstet Gynecol. 2008 Feb;20(1):9-13. doi: 10.1097/GCO.0b013e3282f226a5. Review.

PMID:
18196999
19.

Prognostic and predictive biomarkers in resected colon cancer: current status and future perspectives for integrating genomics into biomarker discovery.

Tejpar S, Bertagnolli M, Bosman F, Lenz HJ, Garraway L, Waldman F, Warren R, Bild A, Collins-Brennan D, Hahn H, Harkin DP, Kennedy R, Ilyas M, Morreau H, Proutski V, Swanton C, Tomlinson I, Delorenzi M, Fiocca R, Van Cutsem E, Roth A.

Oncologist. 2010;15(4):390-404. doi: 10.1634/theoncologist.2009-0233. Epub 2010 Mar 29. Review.

20.

An integrated cell line-based discovery strategy identified follistatin and kallikrein 6 as serum biomarker candidates of breast carcinoma.

Mangé A, Dimitrakopoulos L, Soosaipillai A, Coopman P, Diamandis EP, Solassol J.

J Proteomics. 2016 Jun 16;142:114-21. doi: 10.1016/j.jprot.2016.04.050. Epub 2016 May 7.

PMID:
27168011

Supplemental Content

Support Center